AI-powered clinical assistant for UK healthcare professionals

What steps should I take to ensure safe prescribing for elderly patients with polypharmacy?

Answer

Guideline-Aligned (High Confidence)
Generated by iatroX. Developer: Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner).
Last reviewed: 22 August 2025

To ensure safe prescribing practices for elderly patients with polypharmacy, conduct regular multidisciplinary medication reviews at least annually or more frequently based on patient safety and health needs. These reviews should involve discussing the purpose, benefits, risks, and patient understanding of all prescribed, over-the-counter, and complementary medicines, including adherence and any difficulties with administration or side effects 1.

Assess frailty and multimorbidity carefully as these factors increase the risk of adverse drug events and interactions; consider using validated tools such as gait speed or the PRISMA-7 questionnaire to guide clinical decisions 2.

Adopt a patient-centred approach that takes into account the individual's health priorities, treatment burden, and quality of life, aiming to reduce unnecessary medications and avoid prescribing cascades 2. Engage patients and carers in shared decision-making to improve adherence and address any self-modification of medication regimens 3.

Ensure clear, accurate, and up-to-date documentation and communication between all healthcare professionals involved in the patient's care to prevent fragmentation and errors, including recording indications, duration, monitoring requirements, and any changes promptly in the medical record 1,3.

Prescribe medicines in appropriate quantities (e.g., aligning with a 28-day supply cycle) and monitor 'when required' or variable dose medicines carefully to minimise risks 1.

Provide training and support for healthcare staff involved in prescribing and administering medicines to maintain competence and awareness of safe practices, especially in care home settings 1.

When prescribing opioids or other high-risk medicines for persistent non-cancer pain in older adults, exercise particular caution due to increased sensitivity and risk of adverse effects, balancing pain management with safety considerations (Guerriero, 2017).

Related Questions

Finding similar questions...

This content was generated by iatroX. Always verify information and use clinical judgment.